Belviso BOCUTOX Neurolift Forte

A modern alternative to classic neuromodulation

Belviso BOCUTOX Neurolift Forte has been presented as a neuropeptide lifting-and-stimulating serum, intended for rejuvenating procedures, smoothing facial expression lines, improving skin firmness and supporting fibroblast activity and tissue regeneration. The product has a volume of 6 ml per ampoule and was designed as a formula combining a “botox-like” effect with a biostimulating action.

The product concept responds to one of the significant directions of contemporary aesthetic medicine: preserving natural facial expression while simultaneously reducing excessive tension of the mimic muscles and improving skin quality. Unlike botulinum toxin, whose action consists in blocking neuromuscular transmission, Belviso BOCUTOX Neurolift Forte has been described as a product with a gentler, more superficial and regenerative profile of action. Its aim is not complete immobilisation of the muscles, but a subtle reduction of their activity and an improvement of skin structure.

A dual mechanism of action: “botox-like” and collagen booster

The most important feature of the product is its dual action. The first mechanism is neuromodulating in character, described in the presentation as “botox-like.” It consists in reducing the tension of the mimic muscles, smoothing dynamic wrinkles and achieving a more rested facial appearance without the effect of complete muscle paralysis.

The second mechanism concerns biostimulation. The product has been presented as a “collagen booster,” i.e. a formula supporting fibroblast activation, the synthesis of type I, III and IV collagen, and the improvement of skin elasticity, density and firmness. This combination means that the procedure is not merely a treatment for smoothing mimic wrinkles. Its purpose is also to improve skin quality, accelerate regeneration and strengthen the skin’s structure.

Active ingredients and their biological significance

The Belviso BOCUTOX Neurolift Forte formula is based on neuropeptides, biomimetic peptides, amino acids and low-molecular-weight hyaluronic acid. The presentation indicates, among others, Acetyl Hexapeptide-8, known as Argireline, at a maximum concentration of 10%. This ingredient has been described as a peptide with a “botox-like” action that affects the SNARE complex, reduces the release of acetylcholine and promotes relaxation of the mimic muscles.

A second important ingredient is Acetyl Octapeptide-3, designated SNAP-8, at a maximum concentration of 5%. Its task is to reinforce the effect of Argireline and act synergistically in reducing muscle contractions. The presentation also indicates Palmitoyl Tetrapeptide-7, which has an anti-inflammatory action, reduces the IL-6 cytokine and supports skin regeneration after procedures.

A further component is Palmitoyl Tripeptide-5, known as Syn-Coll, described as a peptide that activates TGF-β and stimulates fibroblasts to produce type I and III collagen. The formula also includes Acetylarginyltryptophyl Diphenylglycine, L-arginine, low-molecular-weight hyaluronic acid and a PBS buffer with 0.9% NaCl, which are intended to support microcirculation, the transport of active substances, hydration, stability and the biocompatibility of the product.

Clinical effect: smoothing without a “frozen” face

According to the presentation, the clinical effects of the product include reduction of mimic wrinkles, especially in the area of the forehead, the eye region and the glabellar (frown) line. The product is also intended to improve the firmness and contour of the facial skin, brighten the complexion, increase skin density and hydration, and accelerate regeneration after aesthetic procedures. The material indicates that a lifting effect may be visible after as few as 1–2 procedures.

A significant advantage of this concept is the absence of a “frozen” face. Belviso BOCUTOX Neurolift Forte has been presented as a product that gently weakens the work of the mimic muscles but does not block them completely. Such a profile of action may be particularly beneficial in patients who expect a natural result, preservation of facial expression and a simultaneous improvement in skin firmness.

The NuTox procedure as therapy between classic botulinum toxin treatments

In the presentation, the NuTox procedure using Belviso BOCUTOX Neurolift Forte has been described as a modern alternative to classic botox, based on neuropeptides with a botox-like action. The product may be considered in people who wish to take a break from botulinum toxin because of skin laxity, a need for regeneration or a weakened response to successive toxin treatments.

The material also indicates the use of the product in so-called “between-botox” periods. According to the presentation, the procedure may be recommended 1.5–2 months after a botulinum toxin injection, in order to support skin regeneration, stimulate fibroblasts to produce collagen and elastin, and restore the skin’s elasticity and radiance. Such use should be treated as part of supportive therapy, and not as a direct equivalent of a medicinal product containing botulinum toxin.

Treatment protocols: mesotherapy, microneedling and device-assisted delivery

The presentation describes several ways of working with the product. The first is needle mesotherapy, performed manually or with a gun. The material indicates a depth of 2–4 mm, a point or papular technique, a volume of 0.02–0.05 ml per point and the use of 3–5 ml of product per face. The recommended series comprises 4–6 procedures performed every 3–4 weeks. The treatment areas are the face, neck, décolletage and the backs of the hands.

The second protocol is the use of the product in Multi-Needle, DermaPen or microneedling procedures. In this variant, the presentation indicates a depth of 0.2–1.0 mm on the face and up to 1.5 mm in the neck and décolletage area. The technique involves applying a thin layer of the product and massaging it in after puncturing, with a recommendation to work using the “wet needling” technique, i.e. maintaining appropriate hydration during the procedure. The aim is increased penetration of the peptides and hyaluronic acid and an evening-out of the skin texture.

The third variant is the use of the Vital Injector 2 device. The presentation describes a depth of 0.2–0.6 mm, a volume of 0.02–0.05 ml per single delivery and a five-needle system with negative pressure, which is intended to enable even introduction of the product. The indicated amount of product is 3–6 ml per procedure, and the schedule comprises 4 procedures every 2–3 weeks, followed by maintenance procedures approximately every 2 months.

Off-label applications and the need for clinical caution

The presentation also contains protocols described as off-label, including schemes for combining Belviso BOCUTOX Neurolift Forte with botulinum toxin in procedures such as NuTox full-face and NuTox Forte. Applications of this kind require particular caution, full medical qualification, knowledge of anatomy, risk assessment, the patient’s informed consent and compliance with the applicable regulations on the use of medicinal products.

From a professional standpoint, the use of the neuropeptide serum alone should be clearly separated from procedures combined with botulinum toxin. Botulinum toxin is a medicinal product, and therefore its use requires appropriate qualifications, documentation and conduct consistent with the product characteristics and the standards of medical practice. Off-label procedures should not be treated as a routine cosmetic scheme, but as an individually considered medical intervention.

Safety and post-procedure recommendations

The presentation indicates that the product should not be used in patients with active inflammation, skin infections or herpes. After the procedure, it is recommended to avoid exposure to the sun, tanning beds and saunas for 48 hours. The material also emphasises not combining the product directly with irritating substances such as acids or retinol.

According to the presentation, Belviso BOCUTOX Neurolift Forte may be combined with procedures such as classic botox, radiofrequency, HIFU or fractional laser, with an indicated interval of about 14 days. In clinical practice, the interval between procedures should always be adapted to the type of procedure, the reactivity of the skin, the patient’s baseline condition and the intensity of earlier interventions.

As regards home care, the presentation recommends not washing the face with soap or alcohol-based products for 24 hours after the procedure. It is advised to use a regenerating cream with peptides, ceramides or PDRN, to ensure adequate hydration of the body, and to perform maintenance procedures every 2–3 months after completing the series.

The significance of the product in regenerative skin therapies

Belviso BOCUTOX Neurolift Forte fits into the trend of therapies that combine superficial neuromodulation with biostimulation of the skin. Its clinical value stems from combining the effect of smoothing facial expression with an improvement in skin quality, which distinguishes it from classic procedures aimed solely at blocking the work of the muscles.

The product may be of particular interest in the treatment of patients with fine mimic wrinkles, loss of skin firmness, a need to brighten the complexion, reduced elasticity and a need for regeneration after other aesthetic procedures. It may also form part of supportive therapy in people who wish to preserve natural facial expression or reduce the frequency of classic botulinum toxin treatments.

Summary

Belviso BOCUTOX Neurolift Forte has been presented as an advanced neuropeptide lifting-and-stimulating serum with a dual profile of action: botox-like and collagen booster. The formula, based on biomimetic peptides, neuropeptides, L-arginine and low-molecular-weight hyaluronic acid, is intended to support the smoothing of mimic wrinkles, improvement of skin firmness, regeneration, hydration and biostimulation of fibroblasts.

The most important feature of the product is the ability to achieve a natural smoothing effect without fully blocking facial expression. As a result, it can be used as a standalone rejuvenating and regenerative therapy, as a supportive procedure between botulinum toxin treatments, and as an element of broader protocols for improving skin quality.

This article is informational and educational in nature and does not replace the product’s instructions for use, procedural training, specialist qualification or the individual clinical decision.